In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer

Journal of Surgical Research

Volumn 69, Issue 1, 1997, Pages 226-231

  Evoy, Denis ^b   Hirschowitz, Edward A ^a   Naama, Hassan A ^b   Li, Xiao Kui ^b   Crystal, Ronald G ^a   Daly, John M ^b   Lieberman, Michael D ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; MESSENGER RNA; PRODRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; CANCER GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INDUCTION; GENE TARGETING; GENE THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; VIRUS GENE;

EID: 0031127632     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5051     Document Type: Conference Paper

References (30)

1. 1. Parker, S., Tong, T., Bolden, S., and Wingo, P. Cancer Statistics, 1996. CA 46: 5, 1996.
2. 2. Algren, J. D. Epidemiology and risk factors in pancreatic cancer. Semin. Oncol. 23: 241, 1996.
3. 3. Warshaw, A. L., and Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med. 326: 455, 1992.
4. 4. Moossa, A. R., and Gamagami, R. A. Diagnosis and staging of pancreatic neoplasms. Surg. Clin. North. Am. 75: 871, 1995.
5. 5. Bakkevold, K. E., Arnesjo, B., and Kambestad, B. Carcinoma of the pancreas and papilla of Vater: Assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients. Eur. J. Surg. Oncol. 18: 494, 1992.
6. 6. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA 91: 8302, 1994.
7. 7. Kaiser, M. H., and Ellenberg, S. S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120: 899, 1985.
8. 8. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., and Richards, C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53: 4619, 1993.
9. 9. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54: 1503, 1994.
10. 10. Hirschowitz, E. H., Ohwada, A., Pascal, W. R., Russi, T. J., and Crystal, R. G. In vivo adenovirus mediated -mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-Fluorocytosine. Hum. Gene Ther. 1055, 1995.
11. 11. Hersh, J., Crystal, R. G., and Bewig, B. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2: 124, 1995.
12. 12. Graham, F. L., Smiley, J., Russell, W. C., and Nairu, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59, 1977.
13. 13. Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C., Yoneyama, K, Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143, 1992.
14. 14. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science. 252: 431, 1991.
15. 15. Senter, P. D., Su, P. C. D., Marquardt, H., Hayden, S., and Linsey, P. Expression of DNA sequences encoding a thermally stable cytosine deaminase from Saccharomyces, United States Patent, Oncogen, a limited partnership, Seattle, WA, 1994.
16. 16. Quaglia, M. G., Carlucci, G., Maurizi, G., and Mazzeo, P. Determination of 5-fluorouracil in 5 fluorocytosine by high performance thin layer chromatography and derivative UV-spectrophotometry. Pharm. Acta. Helv. 63: 347, 1988.
17. 17. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55, 1983.
18. 18. Peplinski, G. R., Tsung, K, Meko, J. B., and Norton, J. A. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta. Surgery 118: 185, 1995.
19. 19. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91: 3054, 1994.
20. 20. Rakesh, K. J. Vascular and interstitial barriers to the delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9: 253, 1990.
21. 21. Znati, C. A., Rosenstein, M., Boucher, Y., Epperly, M. W., Bloomer, W. D., and Jain, R. K. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res. 56: 964, 1996.
22. 22. Kristjansen, P. E., Boucher, Y., and Jain, R. K. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res. 53: 4764, 1993.
23. 23. Toloza, E., Hunt, K, Swisher, S., McBride, W., Lau, R., Pang, S., Rhoades, K, Drake, T., Belldegrun, A., Glaspy, J., and Economou, J. S. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 3: 11, 1995.
24. 24. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004, 1995.
25. 25. Ohwada, A., Hirschowitz, E. H., and R. G., C. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-Fluorocytosine to suppress the growth of colon carcinoma metastatic to the liver. Hum. Gene Ther. 7: 1567, 1996.
26. 26. Cordier, L., Duffour, M. T., Sabourin, J. C., Lee, M. G., Cabannes, J., Ragot, T., Perricaudet, M., and Haddada, H. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 2: 16, 1995.
27. 27. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89: 33, 1992.
28. 28. Consalvo, M., Mullen, C. A., Modesti, A., Musiani, P., Allione, A., Cavallo, F., Giovarelli, M., and Forni, G. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J. Immunol. 154: 5302, 1995.
29. 29. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, J. A., Nye, A., Sampson-Johannes, A., Fattney, F., and McCormick, F. An adenovirus mutant that replicates selectively in p53 deficient human tumor cells. Science 274:373, 1996.
30. 30. Di Giuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van den Berg, F. M., Allison, D. C., Cameron, J. L., and Offerhaus, G. J., Overexpression of p53 protein in adenocarcinoma of the pancreas. Am. J. Clin. Pathol. 101: 684, 1994.